News & Updates

Show Multimedia Only
Theophylline shows promise in SCI-induced bradycardia

Theophylline shows promise in SCI-induced bradycardia

18 Jul 2023

Use of theophylline as an adjunctive therapy appears to lead to favourable outcomes among patients with bradycardia due to acute spinal cord injury (SCI) with an acceptable response to this agent, suggest the results of a study.

18 Jul 2023
Advanced liver fibrosis a red flag for poor outcomes in T2D

Advanced liver fibrosis a red flag for poor outcomes in T2D

18 Jul 2023

Among individuals with type 2 diabetes (T2D), the risk of poor outcomes such as heart failure and hospitalizations is high in the presence of advanced liver fibrosis, according to a study.

18 Jul 2023